MannKind Corp. (MNKD)
3.03
-0.25
(-7.62%)
USD |
NASDAQ |
Mar 02, 16:00
3.05
+0.02
(+0.66%)
After-Hours: 18:18
MannKind EPS Diluted (Quarterly) : -0.0519 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| United Therapeutics Corp. | 7.702 |
| Keros Therapeutics, Inc. | -0.1792 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.95M |
| Revenue (Quarterly) | 111.96M |
| Total Expenses (Quarterly) | 127.90M |
| Enterprise Value | 1.309B |
| Gross Profit Margin (Quarterly) | 69.95% |
| Profit Margin (Quarterly) | -14.24% |
| Earnings Yield | 0.55% |
| Operating Earnings Yield | 5.55% |
| Normalized Earnings Yield | 1.485 |